Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome
Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) coul...
Main Authors: | Matthias Otto, Jörg Krebs, Peter Welker, René Holm, Manfred Thiel, Luciano Gattinoni, Michael Quintel, Charalambos Tsagogiorgas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/3/431 |
Similar Items
-
Avaliação do possível efeito tóxico de um alcano semifluorinado de uso oftalmológico sobre cultura de células Vero Assessment of the possible toxic effect of a semifluorinated alkane on Vero cell culture
by: Paulo Estacia, et al.
Published: (2004-12-01) -
Synthesis and characterization of molecules to study the conformational barriers of fluorocarbon chains
by: Niyogi, Sandip
Published: (2000) -
Development of a murine nose-only inhalation model of influenza: Comparison of disease caused by instilled and inhaled A/PR/8/34
by: Larry E. Bowen, et al.
Published: (2012-05-01) -
Critical characteristics for corticosteroid solution metered dose inhaler bioequivalence
by: Grainger, C.I., et al.
Published: (2019) -
Impact of selected construction elements of capsule-based dry powder inhalers on the manner of drug delivery to the lungs
by: Marcin Odziomek, et al.
Published: (2016-12-01)